|
|
Effects of PKM2 Knockdown on Proliferation and Apoptosis of Human Leukemia Cells and Its Potential Mechanism |
Lu WANG,Li-yuan YANG,Yu-ting TANG,Yao TAO,Li LEI,Yi-pei JING,Xue-ke JIANG,Ling ZHANG() |
College of Laboratory Medicine, Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education,Chongqing Medical University, Chongqing 400016, China |
|
|
Abstract Objective: Effects of PKM2 knockdown on proliferation and apoptosis of human leukemia cells and its potential mechanism were investigated in our experiment. Methods: Lentivirus-based short hairpin RNA (shRNA) vector targeting PKM2 was transfected into K562 cells (shPKM2 group), and the vector-treated cells were named as the Vector group. mRNA and protein levels of PKM2 in K562 cells were determined by qRT-PCR and Western blot techniques, respectively. Cell proliferation activity was evaluated by CCK-8 assay in vitro. Cell cycle and apoptosis rate were analyzed by flow cytometry, the expression levels of apoptosis-related proteins Bax and Bcl-2 were measured by Western blot and the autophagy activity was measured by qRT-PCR and Western blot, respectively. Results: mRNA (t=11.58, P=0.000 3) and protein (t=11.88, P=0.000 3) levels of PKM2 were significantly decreased after PKM2 knockdown in K562 cells. In comparison to the Vector group, cell proliferation was inhibited by PKM2 deleption in shPKM2 group (F=118.87, P<0.000 1). Furthermore, G1-phase cell cycle was arrested, and the cell apoptosis rate was increased after PKM2 knockdown (t=37.23, P<0.000 1). Meanwhile, upregulated pro-apoptotic Bax protein levels (t=15.3, P=0.000 1) and downregulated anti-apoptotic Bcl-2 protein levels (t=9.965, P=0.000 6) were observed in shPKM2 group compared with the Vector group. In addition, decreased expression of PKM2 significantly downregulated LC3II levels (tLC3II=10.32, PLC3II=0.000 5) and elevated p62 levels (tp62=14.59, Pp62=0.000 1) in K562 cells. Finally, autophagy activator rapamycin rescued the inhibitory cell proliferation due to PKM2 knockdown (F=96.32, P<0.000 1). Conclusion: Above-mentioned results indicate that PKM2 knockdown can inhibit cell proliferation and promote cell apoptosis, at least partially through the cell autophagy, and PKM2 might be a potential target in the treatment of leukemia.
|
Received: 21 October 2018
Published: 12 April 2019
|
|
Corresponding Authors:
Ling ZHANG
E-mail: lingzhang@cqmu.edu.cn
|
|
|
[1] |
Pfrepper C, Klink A, Behre G , et al. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation. J Cancer Res Clin Oncol, 2016,142(1):317-324.
doi: 10.1007/s00432-015-2050-y
pmid: 26424692
|
|
|
[2] |
Jang M, Kim S S, Lee J . Cancer cell metabolism: Implications for therapeutic targets. Exp Mol Med, 2013,45:e45.
doi: 10.1038/emm.2013.85
pmid: 24091747
|
|
|
[3] |
Dayton T L, Jacks T , Vander Heiden M G . PKM2, cancer metabolism, and the road ahead. EMBO Rep, 2016,17(12):1721-1730.
doi: 10.15252/embr.201643300
pmid: 27856534
|
|
|
[4] |
Yang W, Lu Z . Pyruvate kinase M2 at a glance. J Cell Sci, 2015,128(9):1655-1660.
doi: 10.1242/jcs.166629
pmid: 25770102
|
|
|
[5] |
Orsini M, Morceau F, Dicato M , et al. Autophagy as a pharmacological target in hematopoiesis and hematological disorders. Biochem Pharmacol, 2018,152:347-361.
doi: 10.1016/j.bcp.2018.04.007
pmid: 29656115
|
|
|
[6] |
Takahashi H, Inoue J, Sakaguchi K , et al. Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells. Oncogene, 2017,36(30):4267-4276.
doi: 10.1038/onc.2017.59
|
|
|
[7] |
Cheng T Y, Yang Y C, Wang H P , et al. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein. Oncogene, 2018,37(13):1730-1742.
doi: 10.1038/s41388-017-0086-y
|
|
|
[8] |
Wang Y H, Israelsen W J, Lee D , et al. Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell, 2014,158(6):1309-1323.
doi: 10.1016/j.cell.2014.07.048
pmid: 25215489
|
|
|
[9] |
Panchabhai S, Schlam I, Sebastian S , et al. PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma. Leukemia, 2017,31(4):991-994.
doi: 10.1038/leu.2016.389
pmid: 28025580
|
|
|
[10] |
Lin Y, Meng F, Lu Z , et al. Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial-mesenchymal transition via Wnt/beta-catenin signaling. Cancer Manag Res, 2018,10:4191-4202.
doi: 10.2147/CMAR
|
|
|
[11] |
Goldberg M S, Sharp P A . Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression. J Exp Med, 2012,209(2):217-224.
doi: 10.1084/jem.20111487
pmid: 22271574
|
|
|
[12] |
Zheng B, Liu F, Zeng L , et al. Overexpression of pyruvate kinase type M2 (PKM2) promotes ovarian cancer cell growth and survival via regulation of cell cycle progression related with upregulated CCND1 and downregulated CDKN1A expression. Med Sci Monit, 2018,24:3103-3112.
doi: 10.12659/MSM.907490
pmid: 29752805
|
|
|
[13] |
Tooze S A, Dikic I . Autophagy captures the Nobel Prize. Cell, 2016,167(6):1433-1435.
doi: 10.1016/j.cell.2016.11.023
pmid: 27912049
|
|
|
[14] |
Polak R , Bierings M B, van der Leije C S , et al. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1 driven B-cell precursor acute lymphoblastic leukemia. Haematologica, 2018, DOI: 10.3324/haematol.2018.193631.
doi: 10.3324/haematol.2018.193631
|
|
|
[15] |
Piya S, Andreeff M, Borthakur G . Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia. Autophagy, 2017,13(1):214-215.
doi: 10.1080/15548627.2016.1245263
pmid: 27797294
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|